InsidersTradesSigma
Track the 梅花生物 share price and the full directors' dealings record of the company, a listed issuer based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Chemicals sector, 梅花生物 has recorded 9 public disclosures. Market capitalisation: €22bn. The latest transaction was reported on 30 April 2026 (Purchase). Among the most active insiders: 常利斌. The full history is free.
9
Insider Decl.
n/a
Thresholds
€23m
8 ops.
Buy Volume
€68,647
1 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 2,469 of 29,063 companies
75.3
score / 100
Value88
Quality62
FCF yld8.8%
Earn yld15%
EV/EBITDA5.0x
ROE14%
Gross mgn19%
Net mgn14%
Debt/EBITDA0.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 30 April 2026
Declarations9 total
9 of 9 declarations
关于 梅花生物
梅花生物是一家专注于化学和材料的公司，在 XSHG 市场上市。它致力于创新化学产品的研发。